bpc 157 prescription only Wolverine Stack Peptide Therapy (BPC-157 + TB-500) BPC-157 - Pure Health Peptides

No adverse effects were noted in clinical trials (ulcerative colitis, phase II) [84,85], and in toxicological studies, a lethal dose (LD1) was not achieved (for review, see [11,12,13,14,24,25])

It's this multifaceted potential that makes it such a compelling subject of study

A smaller but growing body of preclinical literature investigates BPC-157 within neurological and braingut communication models

BPC 157 reduces various arrhythmias (i.e., potassium overdose-induced hyperkalemia (Barisic et al., 2013), digitalis (Balenovic et al., 2009), neuroleptics (i.e., prolonged QTc-intervals that may also be centrally related) (Strinic et al., 2017), bupivacaine (Zivanovic-Posilovic et al., 2016), lidocaine (Lozic et al., 2020), and succinylcholine (Stambolija et al., 2016))

Insurance and pricing Most insurance accepted